Form 4 for CGEM Cullinan Therapeutics, Inc.
Accepted 2025-12-29 00:00:00 ET · period of report 2025-12-23 · accession 0001193125-25-335482 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-29 | 2025-12-23 | CGEM | AHMED NADIM | Pres, CEO, Dir | S - Sale | $10.01 | -9,922 | 420.7K | -2% | -$99.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-23 | S | D | 9,922 | $10.01 | 420,699 | D | — | — |